Sensitization of human uterine cervical cancer cells to radiation using paclitaxel

Current Therapeutic Research - Clinical and Experimental

Volumn 57, Issue 6, 1996, Pages 430-437

  Suzuki, Mitsuaki ^a   Saga, Yasushi ^a   Sekiguchi, Isao ^a   Sato, Ikuo ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; PACLITAXEL; RADIOSENSITIZING AGENT;

ARTICLE; CELL CYCLE S PHASE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RADIOSENSITIVITY; TREATMENT OUTCOME; UTERINE CERVIX CANCER;

EID: 0030056377     PISSN: 0011393x     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(96)80051-8     Document Type: Article

References (14)

1. Plant antitumor agents. VI. The isolation and structure of Taxol, a novel antileukemic and antitumor agent from Taxus brevifolia
2. Promotion of microtubule assembly in vitro by Taxol
3. Taxol stabilizes microtubules in mouse fibroblast cells
4. Taxol: A unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms
5. Phase II study of Taxol in patients with advanced ovarian cancer
6. Phase II trial of Taxol as second-line therapy for ovarian carcinoma: A Gynecologic Oncology Group Study
7. Taxol dose intensification (D.I.) in patients with recurrent ovarian cancer
8. Cyclic X-ray responses in mammalian cells in vitro
9. 1-glycoprotein phenotypes
10. Taxol sensitizes human astrocytoma cells to radiation
11. Investigation of Taxol as a potential radiation sensitizer
12. Taxol sensitizes human ovarian cancer cells to radiation
13. Taxol as a radiation sensitizer: A flow cytometric study
14. Enhancement of tumor radioresponse of a murine mammary carcinoma by paclitaxel